Market Overview

Keryx Biopharmaceuticals, Inc. (NASDAQ: )

0.00 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2018
After-Hours
EPS:
REV:
-0.20
14.996M
-0.15
29.07M
-0.14
28.036M
-6.67%
-3.56%
Q2 2018
Pre-Market
EPS:
REV:
-0.77
15.144M
-0.16
25.73M
-0.18
25.749M
12.5%
0.07%
Q1 2018
Pre-Market
EPS:
REV:
-0.21
11.819M
-0.18
21.98M
-0.18
21.751M

-1.04%
Q4 2017
Pre-Market
EPS:
REV:
-0.32
9.533M

-0.26
18.682M

Q3 2017
Pre-Market
EPS:
REV:
-0.39
6.337M
-0.18
18.04M
-0.20
14.996M
11.11%
-16.87%
Q2 2017
Pre-Market
EPS:
REV:
-0.42
9.288M
-0.18
14.51M
-0.77
15.144M
327.78%
4.37%
Q1 2017
Pre-Market
EPS:
REV:
-0.39
6.825M
-0.20
10.29M
-0.21
11.819M
5%
14.86%
Q4 2016
Pre-Market
EPS:
REV:
-0.36
5.783M
-0.25
8.41M
-0.32
9.533M
28%
13.35%
Q3 2016
Pre-Market
EPS:
REV:
-0.29
4.208M
-0.20
5.37M
-0.39
6.337M
-9500%
1800.74%
Q2 2016
Pre-Market
EPS:
REV:
-0.26
2.514M
-0.28
8.47M
-0.42
9.288M
-50%
9.66%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!